Addition of late contrast enhancement (LCE) CT reportedly bolsters diagnostic rate for patients with acute chest pain who have negative findings on triple-rule-out (TRO) CT.
Emerging research suggests that the use of a multiparametric computed tomography (CT) protocol, including late contrast enhancement (LCE) CT, may enhance the diagnosis of troponin-positive acute chest pain.
In the study, published online in Radiology, the use of triple-rule-out (TRO) CT diagnosed half of the 84 patients in the study with 35 patients being diagnosed with obstructive coronary artery disease (CAD). For the remaining 42 patients who had negative findings with TRO CT, the study authors obtained a LCE CT scan. This led to a diagnosis in 34 of those patients, including 22 patients diagnosed with myocarditis. In other words, the use of LCE CT improved the initial diagnosis rate of TRO CT from 50 percent (42 of 84 patients) to 90 percent (76 of 84 patients).
“Troponin-positive chest pain with unobstructed coronary arteries represents a diagnostic dilemma, and the identification of its cause is of pivotal importance for the management, treatment, and prognostication of patients,” wrote Anna Palmisano, M.D., who is affiliated with the Clinical and Experimental Radiology Unit in the Experimental Imaging Center at the IRCCS San Raffaele Scientific Institute in Milan, Italy, and colleagues. “ … In our study, LCE CT provided a diagnosis in 81 percent of participants with negative findings at TRO CT (34 of 42), similar to what has previously been reported for cardiac MRI.”
The study authors said the findings demonstrate a “significant improvement in CT capability” to achieve a definitive diagnosis for patients with acute chest pain. Palmisano and colleagues also suggested in the study that implementation of the aforementioned CT protocol could result in a quicker diagnosis because it enables radiologists to employ a single CT study to obtain “several pieces of information commonly derived from combined CT and MRI examinations.”
Limitations of the study included a limited contrast-to-noise ratio (CNR) and small increase in radiation exposure associated with the use of LCE CT as well as a limited patient sample size, according to the study authors. They suggested that larger trials are necessary to assess the cost-effectiveness and clinical value of the study’s CT protocol.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.